Cargando…
Peroxiredoxin 1 – an antioxidant enzyme in cancer
Peroxiredoxins (PRDXs), a ubiquitous family of redox‐regulating proteins, are reported of potential to eliminate various reactive oxygen species (ROS). As a major member of the antioxidant enzymes, PRDX1 can become easily over‐oxidized on its catalytically active cysteine induced by a variety of sti...
Autores principales: | Ding, Chenbo, Fan, Xiaobo, Wu, Guoqiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192802/ https://www.ncbi.nlm.nih.gov/pubmed/27653015 http://dx.doi.org/10.1111/jcmm.12955 |
Ejemplares similares
-
Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics
por: Ding, Chenbo, et al.
Publicado: (2018) -
Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model
por: Ding, Chenbo, et al.
Publicado: (2016) -
Overexpression of PEAK1 contributes to epithelial–mesenchymal transition and tumor metastasis in lung cancer through modulating ERK1/2 and JAK2 signaling
por: Ding, Chenbo, et al.
Publicado: (2018) -
Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels
por: Ding, Chenbo, et al.
Publicado: (2017) -
ERCC1_202 Is A Prognostic Biomarker in Advanced Stage Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy
por: Wang, Xiyong, et al.
Publicado: (2017)